Eszopiclone
Brand names: Lunesta (US)
Eszopiclone is a non-benzodiazepine (Z-drug) hypnotic used for the short-term treatment of insomnia.
ClinCalc Pro is rebuilding its dose data from primary open sources — the manufacturer SmPC (eMC), the WHO Model Formulary and other official references — under clinician review. This drug's structured dose is not yet published here. Confirm all doses against the product SmPC and your local formulary before prescribing.
Clinical monograph
How it works
It acts at the benzodiazepine site of the GABA-A receptor to enhance GABA-mediated inhibition, producing sedative and hypnotic effects.
Prescribing in practice
- Like other hypnotics, it carries a risk of dependence, tolerance and next-day impairment, so use should be limited to the shortest effective period.
- Combination with alcohol, opioids or other CNS depressants increases sedation and respiratory depression risk.
- Complex sleep behaviours such as sleep-walking and sleep-driving have been reported with Z-drugs and warrant discontinuation if they occur.
Monitoring
Monitor for next-day sedation, dependence and any complex sleep behaviours during treatment.
Counselling the patient
- Take only when you can have a full night's sleep and avoid alcohol.
- May impair driving the next morning.
- Use for the shortest time possible and do not stop abruptly after prolonged use.
Evidence & guidelines
Z-drugs are recommended only for short-term insomnia, consistent with NICE guidance on hypnotic use.
Reference: NICE CKS Insomnia; DVLA guidance; Drug verified in RxNorm (NLM); confirm dosing against the manufacturer SPC (eMC). Verify against your local formulary and current prescribing references before prescribing. Monograph status: clinician-reviewed (2026-07-04).
Related
Curated clinical cross-links plus same-class fallbacks.
- Vancomycin Dosing Calculator · Drug Dosing
- Phenytoin Correction for Albumin / Renal Failure · Drug Dosing
- Local Anaesthetic Maximum Dose Calculator · Drug Dosing
- Tisdale Risk Score for QT Prolongation · Arrhythmia
- Bazett Corrected QT Interval (QTc) Calculator · Arrhythmia
- DAPT Score for Dual Antiplatelet Therapy Duration · Antiplatelet Therapy
- Acute Behavioural Disturbance / Rapid Tranquillisation · RCEM 2022; RCPsych 2022; NICE NG10
- Self-Harm Presentation · NICE NG225 (2022)
- Capacity Assessment (Mental Capacity Act) · MCA 2005; Code of Practice
- Acute Psychosis Management · NICE CG178 2014
- Depression Management · NICE CG90 2022
- Lithium Therapy Monitoring · NICE CG185